Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (SHE:301130)
China flag China · Delayed Price · Currency is CNY
26.52
-1.10 (-3.98%)
Sep 10, 2026, 3:04 PM CST

SHE:301130 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
112.3729.51190.68334.37202.78148.63
Short-Term Investments
--0.052.760.141.57
Trading Asset Securities
111.41206.9584.93213.15413.1765
Cash & Short-Term Investments
223.77236.46275.65550.28616.08215.2
Cash Growth
-13.99%-14.22%-49.91%-10.68%186.28%22.20%
Accounts Receivable
50.7955.7357.4349.1456.7858.44
Other Receivables
3.472.353.963.663.233.36
Receivables
54.2658.0861.3952.8160.0161.8
Inventory
31.7228.1927.9727.3620.726.58
Other Current Assets
24.1520.147.893.317.3711.35
Total Current Assets
333.9342.86372.91633.76704.17314.93
Property, Plant & Equipment
546.81538.02507.79371.64267.94240.97
Long-Term Investments
11----
Goodwill
30.5730.5730.57---
Other Intangible Assets
135.0696.7799.8525.5726.6327.68
Long-Term Deferred Tax Assets
11.2810.027.927.597.857.9
Long-Term Deferred Charges
0.860.86----
Other Long-Term Assets
5.8741.4743.5428.6310.423.13
Total Assets
1,0651,0621,0631,0671,017594.61

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
57.6248.8442.4328.456.126.24
Accrued Expenses
2.2419.641714.4620.8821.34
Short-Term Debt
12.1311.5310---
Current Portion of Leases
-0.080.120.12--
Finance Div. Other Current Liabilities
----1.5-
Current Income Taxes Payable
1.6302.080.48-0.08
Current Unearned Revenue
4.663.032.425.416.33.3
Other Current Liabilities
21.995.35.064.783.943.73
Total Current Liabilities
100.2888.4279.1153.738.7434.69
Long-Term Leases
--0.080.2--
Long-Term Unearned Revenue
31.8433.637.1229.6132.735.78
Long-Term Deferred Tax Liabilities
4.624.785.110.740.28-
Other Long-Term Liabilities
---0.08--
Total Liabilities
164.57126.8121.4184.3371.7170.47

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
76.4976.4980.880.880.860.6
Additional Paid-In Capital
364.22363.57461.37461.37461.3790.64
Retained Earnings
460.93462.95460.94440.69403.11372.9
Treasury Stock
-30.99--100.01---
Comprehensive Income & Other
0.711.252.64---
Total Common Equity
871.36904.27905.75982.86945.29524.14
Minority Interest
29.430.5135.42---
Shareholders' Equity
900.77934.78941.16982.86945.29524.14
Total Liabilities & Equity
1,0651,0621,0631,0671,017594.61

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
39.9811.6110.20.32--
Net Cash (Debt)
183.79224.85265.46549.96616.08215.2
Net Cash Growth
-26.49%-15.30%-51.73%-10.73%186.28%22.20%
Net Cash Per Share
2.412.943.416.817.963.55
Filing Date Shares Outstanding
75.4876.4976.4980.880.880.8
Total Common Shares Outstanding
75.4876.4976.4980.880.860.6
Working Capital
233.62254.44293.8580.06665.44280.24
Book Value Per Share
11.5411.8211.8412.1611.708.65
Tangible Book Value
705.74776.93775.33957.29918.66496.46
Tangible Book Value Per Share
9.3510.1610.1411.8511.378.19
Buildings
-510.46396.8306.44276.72265.7
Machinery
-162.11121.2108.6104.63102.37
Construction In Progress
-95.71192.83134.8652.5313.93